Literature DB >> 17521963

Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese.

Patrick Kwan1, Larry Baum, Virginia Wong, Ping Wing Ng, Colin Ht Lui, Ngai Chuen Sin, Andrew C F Hui, Evelyn Yu, Lawrence K S Wong.   

Abstract

There is accumulating evidence to suggest that overexpression of efflux drug transporters at the blood-brain barrier, by reducing antiepileptic drug (AED) accumulation in the seizure foci, contributes to drug resistance in epilepsy. P-glycoprotein, encoded by the ABCB1 gene, is the most studied drug transporter. There are conflicting data as to whether the CC genotype of the ABCB1 3435C>T polymorphism is associated with drug resistance in Caucasian patients with epilepsy. We investigated this association in ethnic Chinese. ABCB1 3435C>T was genotyped in 746 Han Chinese patients with epilepsy and 179 controls. Patients with drug-resistant epilepsy were more likely to have the TT genotype compared with those with drug-responsive epilepsy (16.7% vs 7.4%, odds ratio=2.5, 95% confidence interval=1.4-4.6, P=0.0009). Our results contrast with those of studies of Caucasians, and highlight the complexity of the possible role of this polymorphism in AED response in different ethnic populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521963     DOI: 10.1016/j.yebeh.2007.04.013

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  24 in total

Review 1.  Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.

Authors:  Loqman A Mohamed; Shashirekha Markandaiah; Silvia Bonanno; Piera Pasinelli; Davide Trotti
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

2.  Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients.

Authors:  Mehri Maleki; Mohammad Sayyah; Fatemeh Kamgarpour; Morteza Karimipoor; Aida Arab; Anahita Rajabi; Kourosh Gharagozli; Ahmad Reza Shamshiri; Esmaeil Shahsavand Ananloo
Journal:  Iran Biomed J       Date:  2010-07

3.  Biomarkers for antiepileptic drug response.

Authors:  Tracy A Glauser
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

4.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

5.  Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the ABCB1 gene: implications for drug-resistant epilepsy.

Authors:  Anna Heinrich; Xiao-Bo Zhong; Theodore P Rasmussen
Journal:  Curr Opin Toxicol       Date:  2018-12-18

6.  Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis.

Authors:  Wei-Ping Lv; Ren-Feng Han; Zhi-Rong Shu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 7.  Gene polymorphisms and their role in epilepsy treatment and prognosis.

Authors:  Ortrud K Steinlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-16       Impact factor: 3.000

8.  Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI.

Authors:  Shaun D Darrah; Megan A Miller; Dianxu Ren; Nichole Z Hoh; Joelle M Scanlon; Yvette P Conley; Amy K Wagner
Journal:  Epilepsy Res       Date:  2012-07-26       Impact factor: 3.045

9.  Maternal medication use, fetal 3435 C>T polymorphism of the ABCB1 gene, and risk of isolated septal defects in a Han Chinese population.

Authors:  Chuan Wang; Kaiyu Zhou; Liang Xie; Yifei Li; Yalan Zhan; Lina Qiao; Chaoyi Qin; Ruiqi Liu; Yimin Hua
Journal:  Pediatr Cardiol       Date:  2014-04-17       Impact factor: 1.655

10.  Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.

Authors:  J'mir L Cousar; Yvette P Conley; F Anthony Willyerd; Ajit A Sarnaik; Ava M Puccio; Philip E Empey; Patrick M Kochanek; Michael J Bell; David O Okonkwo; Robert S B Clark
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.